The clinical pharmacogeneticist: An emerging regulatory scientist at the US Food and Drug Administration

Ítems similars

• Review of the Drug Trials Snapshots Program of the US Food and Drug Administration: Women in Cardiovascular Drug Trials
  per: Whyte, John, et al.
  Publicat: (2017)
• US Food and Drug Administration Regulatory Programs for Innovative Technologies
  per: Brodie, Frank, et al.
  Publicat: (2019)
• US Food and Drug Administration regulatory updates in neuro-oncology
  per: Mehta, Gautam U., et al.
  Publicat: (2021)
• A Systematic Assessment of US Food and Drug Administration Dosing Recommendations For Drug Development Programs Amenable to Response-Guided Titration
  per: Wang, Lingshan, et al.
  Publicat: (2020)
• Enrichment Strategies in Pediatric Drug Development: An Analysis of Trials Submitted to the US Food and Drug Administration
  per: Green, Dionna J., et al.
  Publicat: (2018)